Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Adenoid Cystic × Epirubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 78 Triple Negative Breast Neoplasms 15 Stomach Neoplasms 12 Inflammatory Breast Neoplasms 11 Esophageal Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Testicular Neoplasms 3 Lymphoma 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Lymphoma, B-Cell, Marginal Zone 2 Carcinoma, Hepatocellular 2 Adenocarcinoma Of Esophagus 2 Women With Primary Breast Cancer 1 Upper Tract Urothelial Carcinoma 1 Thymoma 1 Testicular Germ Cell Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Rare Tumour 1 Prostatic Neoplasms 1 Primary Breast Cancer 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Micrometastasis 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 3 apatinib 3 Magnetic Resonance Spectroscopy 3 lenvatinib 2 Specimen Handling 2 Nivolumab 2 Imatinib Mesylate 2 Cisplatin 2 Carboplatin 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 regorafenib 1 gallium 68 PSMA-11 1 enfortumab vedotin 1 cabozantinib 1 amivantamab 1 Tretinoin 1 Radiation 1 Pemetrexed 1 Nelfinavir 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lutetium-177 1 Lutetium 1 Ipilimumab 1 Glutamate Carboxypeptidase II 1 Everolimus 1 Etoposide 1 Epirubicin 1 Endoscopic Mucosal Resection 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07320508 2026-01-21

EIC-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡